WALTHAM, Mass., May 20, 2015 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO), an oncology-focused biopharmaceutical company, announced today that Lonnie Moulder, CEO of TESARO, will present an overview of TESARO's business and development programs at the Jefferies 2015 Global Healthcare Conference at the Grand Hyatt hotel in New York City on Wednesday, June 3, 2015 at 2:30 PM ET. A live webcast of this presentation will be available by visiting the Investors section of the TESARO website at www.tesarobio.com. An archived replay of the webcast will be available on the Company's website for 14 days after the conference.
About TESARO
TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.